Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$6K Buy
581
+569
+4,742% +$5.33K ﹤0.01% 9363
2014
Q2
$0 Sell
12
-2,899
-100% -$28.1K ﹤0.01% 11101
2014
Q1
$31K Buy
+2,911
New +$26.9K ﹤0.01% 7511
2013
Q4
Sell
-1,490
Closed -$8K 11055
2013
Q3
$8K Sell
1,490
-459
-24% -$2.35K ﹤0.01% 9058
2013
Q2
$8K Buy
+1,949
New +$8.79K ﹤0.01% 8911

Other funds holding NCIT

UBS's NCIT Position: Q3 2014 in Review

UBS increased its NCI, Inc. (NCIT) stake by 4,742% in Q3 2014, buying an estimated $5.33K and bringing the position to 581 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #9363.

UBS first reported a position in NCIT in Q2 2013 and has held it in 5 quarters since. The position peaked at $31K in Q1 2014. 49 funds tracked by Wall St. Rank hold NCIT as of Q3 2014.

  • UBS held 581 shares of NCI, Inc. worth $6K as of Q3 2014.
  • UBS bought 569 NCI, Inc. shares in Q3 2014, an estimated $5.33K.
  • NCI, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9363 holding.
  • UBS first reported a position in NCI, Inc. in Q2 2013 and has held it in 5 quarters since.
  • UBS's NCI, Inc. position peaked at $31K in Q1 2014.
  • 49 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.